查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842097

全球生物製程檢驗市場：市場規模、佔有率和趨勢分析（按測試類型、階段、方法和地區分類），細分市場預測（2025-2033 年）

Bioprocess Validation Market Size, Share & Trends Analysis Report By Testing Type (Extractables & Leachables Testing, Bioprocess Residuals Testing), By Stage (Process Design, Process Qualification), By Mode, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

生物製程檢驗市場摘要

全球生物製程檢驗市場預計在 2024 年達到 4.855 億美元，預計到 2033 年將達到 10.5 億美元，2025 年至 2033 年的複合年成長率為 9.01%。

成長的促進因素包括對生技藥品和生物相似藥的需求不斷成長、對產品安全性和有效性的嚴格監管要求，以及生產中一次性使用系統的日益普及。

此外，隨著生物製藥公司擴大轉向外包驗證服務以降低成本並縮短時間，預計市場將進一步成長。

提高生技藥品和生物相似藥的產量

生技藥品和生物相似藥產量的不斷成長推動了生物製程檢驗的需求。生技藥品，包括單株抗體、重組蛋白、疫苗以及細胞和基因療法等先進療法，結構高度複雜，對生產過程中的變異性非常敏感。在生產的每個階段——上游、下游以及最終填充/包裝——進行嚴格的驗證，對於確保產品的安全性、有效性和一致性至關重要。此外，隨著主要生物製藥專利到期，生物相似藥市場迅速成長，迫使生產商驗證其工藝，以證明其與參考產品的可比性，從而滿足嚴格的監管要求。不斷成長的生物製藥研發管線以及全球對更具成本效益的治療方案的需求，使得驗證成為生物製造過程中不可或缺的環節。

除了產品創新之外，監管合規和不斷發展的製造技術也在進一步推動市場成長。 FDA、EMA 和 PMDA 等機構發布的嚴格指南要求對製程、分析方法和設備進行全面驗證，以確保患者安全。一次性生物製程系統的轉變也推動了對可萃取物和可萃取物檢測的需求，以確保產品純度。此外，將驗證工作外包給受託製造廠商)可以幫助企業降低成本、縮短生產週期並獲得專業知識。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章 市場因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 附隨市場展望
  • 市場趨勢與展望
  • 市場動態
    • 市場促進因素的影響分析
    • 市場限制因素的影響分析
  • 商業環境分析
    • PESTLE分析
    • 波特五力分析

第4章 依測試類型進行業務分析

  • 儀錶板：按考試類型
  • 全球生物製程檢驗市場：按測試類型分類的差異分析
  • 全球生物製程檢驗市場規模及趨勢分析（按測試類型分類）（2021-2033 年）
  • 可萃取物和可浸出物檢測
    • 全球可萃取物和可浸出物檢測市場：估計值和預測（2021-2033 年）
  • 生物製程殘留物檢測
    • 全球生物製程殘留物檢測市場：估計值與預測（2021-2033）
  • 病毒清除檢測
    • 全球病毒清除檢測市場：估計值與預測（2021-2033）
  • 過濾和發酵系統測試
    • 全球過濾和發酵系統測試市場：估計值和預測（2021-2033）
  • 其他
    • 全球其他地區市場：估計值與預測（2021-2033 年）

第5章：分階段業務分析

  • 儀錶板：階段
  • 全球生物製程檢驗市場：按階段分類的差異分析
  • 全球生物製程檢驗市場規模及發展趨勢分析（按階段分類，2021-2033 年）
  • 流程設計
    • 全球製程設計市場：估計值與預測（2021-2033）
  • 工藝合格
    • 全球製程合格市場：估計值與預測（2021-2033）
  • 持續過程檢驗
    • 全球連續製程檢驗市場：估計值與預測（2021-2033）

第6章：依方法論進行業務分析

  • 儀錶板：按方法論
  • 全球生物檢驗市場：依方法論分類的差異分析
  • 全球生物製程檢驗市場規模及趨勢分析（依方法論分類）（2021-2033 年）
  • 內部生產
    • 全球內部製造市場：估計值與預測（2021-2033）
  • 外包
    • 全球外包市場：估計值與預測（2021-2033）

第7章 生物製程檢驗市場：區域估算和趨勢分析（按測試類型、階段和方法分類）

  • 區域儀錶板
  • 市場規模預測及趨勢分析（2021-2033）
  • 北美洲
    • 北美生物檢驗市場（2021-2033）
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲生物檢驗市場（2021-2033）
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區生物檢驗市場（2021-2033）
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲生物檢驗市場（2021-2033）
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 中東和非洲生物檢驗市場（2021-2033）
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場分析（2024）
  • 公司簡介/上市公司
    • Eurofins Scientific, Inc.
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • Lonza
    • Charles River Laboratories
    • SGS SA
    • Toxikon Corporation
    • Danaher
    • Cobetter Filtration Equipment Co., Ltd.
    • Merck KGaA
Product Code: GVR-4-68040-022-0

Bioprocess Validation Market Summary

The global bioprocess validation market size was estimated at USD 485.5 million in 2024 and is projected to reach USD 1.05 billion by 2033, growing at a CAGR of 9.01% from 2025 to 2033. Growth is driven by the rising demand for biologics and biosimilars, stringent regulatory requirements for product safety and efficacy, and the increasing adoption of single-use systems in manufacturing.

Moreover, biopharmaceutical companies' shift toward outsourcing validation services to reduce costs and accelerate time-to-market is expected to support market expansion.

Rising biologics and biosimilars production

The rising production of biologics and biosimilars strongly drives the demand for bioprocess validation. Biologics such as monoclonal antibodies, recombinant proteins, vaccines, and advanced therapies like cell and gene therapies are highly complex and sensitive to manufacturing variations. To ensure product safety, efficacy, and consistency, rigorous validation of every production stage, upstream, downstream, and final fill/finish is critical. Moreover, with the rapid growth of the biosimilars market following the expiration of major biologic patents, manufacturers are under increasing pressure to validate their processes to demonstrate comparability with reference products in line with strict regulatory requirements. This growing biologic pipeline and the global push for more cost-effective therapeutic solutions have made validation an indispensable step in biomanufacturing.

Beyond product innovation, regulatory compliance, and evolving manufacturing technologies further accelerate market growth. Stringent guidelines issued by agencies such as the FDA, EMA, and PMDA require thorough validation of processes, analytical methods, and equipment to safeguard patient safety. The shift toward single-use bioprocessing systems has also intensified demand for extractables and leachable testing to ensure product purity. Moreover, outsourcing validation activities to contract research and manufacturing organizations allows companies to reduce costs, speed up production timelines, and access specialized expertise.

Global Bioprocess Validation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bioprocess validation market report on the basis of testing type, stage, mode, and regioN

  • Testing Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Extractables & Leachables Testing
  • Bioprocess Residuals Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others
  • Stage Outlook (Revenue, USD Million, 2021 - 2033)
  • Process Design
  • Process Qualification
  • Continued Process Verification
  • Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • In house
  • Outsourced
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Testing Type
    • 1.2.2. Stage
    • 1.2.3. Mode
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Impact Analysis
      • 3.3.1.1. Rising biologics and biosimilars production
      • 3.3.1.2. Stringent regulatory requirements
    • 3.3.2. Market Restraint Impact Analysis
      • 3.3.2.1. Cost associated with validation process
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. PORTER'S Five Forces Analysis

Chapter 4. Testing Type Business Analysis

  • 4.1. Testing Type Segment Dashboard
  • 4.2. Global Bioprocess Validation Market Testing Type, Movement Analysis
  • 4.3. Global Bioprocess Validation Market Size & Trend Analysis, by Testing Type, 2021 to 2033 (USD Million)
  • 4.4. Extractable & Leachables Testing
    • 4.4.1. Global extractable & leachables testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Bioprocess Residuals Testing
    • 4.5.1. Global bioprocess residuals testing media market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Viral Clearance Testing
    • 4.6.1. Global viral clearance testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Filtration & Fermentation Systems Testing
    • 4.7.1. Global filtration & fermentation systems testing market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Global others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Stage Business Analysis

  • 5.1. Stage Segment Dashboard
  • 5.2. Global Bioprocess Validation Market Stage, Movement Analysis
  • 5.3. Global Bioprocess Validation Market Size & Trend Analysis, by Stage, 2021 to 2033 (USD Million)
  • 5.4. Process Design
    • 5.4.1. Global process design market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Process Qualification
    • 5.5.1. Global process qualification market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Continued Process Verification
    • 5.6.1. Global continued process verification market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Mode Business Analysis

  • 6.1. Mode Segment Dashboard
  • 6.2. Global Bioprocess Validation Market Application, Movement Analysis
  • 6.3. Global Bioprocess Validation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. In House
    • 6.4.1. Global in-house market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Outsourced
    • 6.5.1. Global outsourced market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Bioprocess Validation Market: Regional Estimates and Trend Analysis, by By Testing Type, By Stage, & Mode

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 7.3. North America
    • 7.3.1. North America bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico bioprocess validation market, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway bioprocess validation market, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea bioprocess validation market, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina bioprocess validation market, 2021 - 2033 (USD Million)
  • 7.7. MEA
    • 7.7.1. MEA bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Saudi Arabia bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. UAE bioprocess validation market, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait bioprocess validation market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Eurofins Scientific, Inc.
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Sartorius AG
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Thermo Fisher Scientific Inc.
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Lonza
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Charles River Laboratories
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. SGS S.A
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Toxikon Corporation
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Danaher
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Cobetter Filtration Equipment Co., Ltd.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Merck KGaA
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 4 Global bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 5 Global bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 6 North America bioprocess validation market by country, 2021 - 2033 (USD Million)
  • Table 7 North America bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 8 North America bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 9 North America bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 10 U.S. bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 11 U.S. bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 12 U.S. bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 13 Canada bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 14 Canada bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 15 Canada bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 16 Mexico bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 17 Mexico bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 18 Mexico bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 19 Europe bioprocess validation market by country, 2021 - 2033 (USD Million)
  • Table 20 Europe bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 21 Europe bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 22 Europe bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 23 UK bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 24 UK bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 25 UK bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 26 Germany bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 27 Germany bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 28 Germany bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 29 France bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 30 France bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 31 France bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 32 Italy bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 33 Italy bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 34 Italy bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 35 Spain bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 36 Spain bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 37 Spain bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 38 Denmark bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 39 Denmark bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 40 Denmark bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 41 Sweden bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 42 Sweden bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 43 Sweden bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 44 Norway bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 45 Norway bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 46 Norway bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific bioprocess validation market by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 51 China bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 52 China bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 53 China bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 54 Japan bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 55 Japan bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 56 Japan bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 57 India bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 58 India bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 59 India bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 60 Australia bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 61 Australia bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 62 Australia bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 63 Thailand bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 64 Thailand bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 65 Thailand bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 66 South Korea bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 67 South Korea bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 68 South Korea bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 69 Latin America bioprocess validation market by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 71 Latin America bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 72 Latin America bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 73 Brazil bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 74 Brazil bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 75 Brazil bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 76 Argentina bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 77 Argentina bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 78 Argentina bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa bioprocess validation market by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 83 South Africa bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 84 South Africa bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 85 South Africa bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 89 UAE bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 90 UAE bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 91 UAE bioprocess validation market by mode, 2021 - 2033 (USD Million)
  • Table 92 Kuwait bioprocess validation market by testing type, 2021 - 2033 (USD Million)
  • Table 93 Kuwait bioprocess validation market by stage, 2021 - 2033 (USD Million)
  • Table 94 Kuwait bioprocess validation market by mode, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market summary, 2024 (USD Million)
  • Fig. 9 Market segmentation & scope
  • Fig. 10 Market driver impact
  • Fig. 11 Market restraint impact
  • Fig. 12 Porter's analysis
  • Fig. 13 SWOT analysis
  • Fig. 14 Bioprocess validation market: Testing type outlook and key takeaways
  • Fig. 15 Bioprocess validation market: Testing type movement analysis
  • Fig. 16 Global extractables & leachables testing market, 2021 - 2033 (USD Million)
  • Fig. 17 Global bioprocess residuals testing market, 2021 - 2033 (USD Million)
  • Fig. 18 Global viral clearance testing market, 2021 - 2033 (USD Million)
  • Fig. 19 Global filtration & fermentation systems testing market, 2021 - 2033 (USD Million)
  • Fig. 20 Bioprocess validation market: Stage outlook and key takeaways
  • Fig. 21 Bioprocess validation market: Stage movement analysis
  • Fig. 22 Global process design market, 2021 - 2033 (USD Million)
  • Fig. 23 Global process qualification market, 2021 - 2033 (USD Million)
  • Fig. 24 Global continued process verification market, 2021 - 2033 (USD Million)
  • Fig. 25 Global others market, 2021 - 2033 (USD Million)
  • Fig. 26 Bioprocess validation market: Mode outlook and key takeaways
  • Fig. 27 Bioprocess validation market: Mode movement analysis
  • Fig. 28 Global in house market, 2021 - 2033 (USD Million)
  • Fig. 29 Global outsourced market, 2021 - 2033 (USD Million)
  • Fig. 30 Bioprocess validation market: Regional outlook and key takeaways
  • Fig. 31 North America bioprocess validation market, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. key country dynamics
  • Fig. 33 U.S. bioprocess validation market, 2021 - 2033 (USD Million)
  • Fig. 34 Canada key country dynamics
  • Fig. 35 Canada bioprocess validation market, 2021 - 2033 (USD Million)
  • Fig. 36 Mexico key country dynamics
  • Fig. 37 Mexico bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Europe bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 39 UK key country dynamics
  • Fig. 40 UK bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Germany key country dynamics
  • Fig. 42 Germany bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 France key country dynamics
  • Fig. 44 France bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Italy key country dynamics
  • Fig. 46 Italy bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Spain key country dynamics
  • Fig. 48 Spain bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark key country dynamics
  • Fig. 50 Denmark bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Sweden key country dynamics
  • Fig. 52 Sweden bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Norway key country dynamics
  • Fig. 54 Norway bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Rest of Europe key country dynamics
  • Fig. 56 Rest of Europe bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Asia-Pacific bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 58 China key country dynamics
  • Fig. 59 China bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Japan key country dynamics
  • Fig. 61 Japan bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 62 India key country dynamics
  • Fig. 63 India bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Australia key country dynamics
  • Fig. 65 Australia bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Thailand key country dynamics
  • Fig. 67 Thailand bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 68 South Korea key country dynamics
  • Fig. 69 South Korea bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Rest of Asia Pacific key country dynamics
  • Fig. 71 Rest of Asia Pacific bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Latin America bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Brazil key country dynamics
  • Fig. 74 Brazil bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Argentina key country dynamics
  • Fig. 76 Argentina bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Rest of Latin America key country dynamics
  • Fig. 78 Rest of Latin America bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 79 Middle East Asia bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 80 South Africa key country dynamics
  • Fig. 81 South Africa bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Saudi Arabia key country dynamics
  • Fig. 83 Saudi Arabia bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 84 UAE key country dynamics
  • Fig. 85 UAE bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 86 Kuwait key country dynamics
  • Fig. 87 Kuwait bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 88 Rest of Middle East & Africa key country dynamics
  • Fig. 89 Rest of Middle East & Africa bioprocess validation market estimates and forecast, 2021 - 2033 (USD Million)